Skip to main content Skip to section navigation Skip to footer
TCBiopharm.com

TC BioPharm Limited

  • Investors
  • Overview
  • News
    • Overview
    • Press Releases
    • Media Coverage
    • Email Alerts
  • Events & Presentations
    • Overview
    • Events
    • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • General Meeting
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News

News

  • Overview
  • Press Releases
  • Media Coverage
  • Email Alerts
      Feb 10, 2022 10:01pm EST

      TC Biopharm Announces Pricing of Upsized $17.5 Million Initial Public Offering and Nasdaq Listing

      Jan 18, 2022 8:30am EST

      TC BioPharm to Participate in Advanced Therapies Week January 25-28

      Jan 11, 2022 8:30am EST

      TC BioPharm (Holdings) Limited Names Chris Camarra Executive Vice President, Communications

      Oct 13, 2021 8:30am EDT

      TC BioPharm Announces Launch of COVID-19 Phase I/II Human Trial

      Sep 20, 2021 10:00am EDT

      TC BioPharm Announces Dr. Sebastian Wanless as Senior Clinical Director

      Aug 12, 2021 1:25pm EDT

      TC BioPharm Named as Top 5 Female Powered Companies in United Kingdom

      Apr 24, 2019 4:39am EDT

      TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients

      Mar 29, 2019 5:30am EDT

      Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director

      Feb 25, 2019 4:00am EST

      Immunotherapy Company TC BioPharm Partners with Trinity College Dublin to Develop V Delta 1 γδ T Cell-based Cancer Treatments

      Jan 22, 2019 5:55am EST

      TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

      • arrow_back
      • 1…
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
      • 12
      rss_feed News RSS
      • Email Alerts
      • Contacts
      • RSS News Feed
      • Visit us on Facebook
      • Visit us on Twitter
      • Visit us on LinkedIn
      ©2025 TC BioPharm Limited. All Rights Reserved.
      Privacy Policy Disclaimer Sitemap

      This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.

      I Accept